메뉴 건너뛰기




Volumn 26, Issue 7, 2011, Pages 2144-2153

Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC)

Author keywords

apoptosis; human tubular cell; IL 2 receptor; interleukin 2; kidney

Indexed keywords

ALKALINE PHOSPHATASE; BASILIXIMAB; CASPASE 8; CYTOKERATIN; DIPEPTIDYL PEPTIDASE IV; FLICE INHIBITORY PROTEIN; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOCORTIN 5; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; UVOMORULIN; VIMENTIN;

EID: 79959977079     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq714     Document Type: Article
Times cited : (16)

References (34)
  • 2
    • 0029855513 scopus 로고    scopus 로고
    • Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases
    • Miyazaki T, Taniguchi T. Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases. Cancer Surv 1996; 27: 25-40. (Pubitemid 26363821)
    • (1996) Cancer Surveys , vol.27 , pp. 25-40
    • Miyazaki, T.1    Taniguchi, T.2
  • 4
    • 67449100081 scopus 로고    scopus 로고
    • Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation
    • Mandelbrot D. Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation. J Am Soc Nephrol 2009; 20: 1170-1171.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 1170-1171
    • Mandelbrot, D.1
  • 5
    • 0033608073 scopus 로고    scopus 로고
    • Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin- 2-receptor monoclonal antibody
    • DOI 10.1097/00007890-199901270-00016
    • Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation 1999; 67: 276-284. (Pubitemid 29066355)
    • (1999) Transplantation , vol.67 , Issue.2 , pp. 276-284
    • Kahan, B.D.1    Rajagopalan, P.R.2    Hall, M.3
  • 6
    • 0035166183 scopus 로고    scopus 로고
    • Role of anti-interleukin-2 receptor antibodies in kidney transplantation
    • Cibrik DM, Kaplan B, Meier-Kriesche HU. Role of anti-interleukin-2 receptor antibodies in kidney transplantation. BioDrugs 2001; 15: 655-666. (Pubitemid 33078986)
    • (2001) BioDrugs , vol.15 , Issue.10 , pp. 655-666
    • Cibrik, D.M.1    Kaplan, B.2    Meier-Kriesche, H.-U.3
  • 7
    • 28644435097 scopus 로고    scopus 로고
    • Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: A review
    • DOI 10.1111/j.1399-0012.2005.00417.x
    • Sandrini S. Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review. Clin Transplant 2005; 19: 705-710. (Pubitemid 41748720)
    • (2005) Clinical Transplantation , vol.19 , Issue.6 , pp. 705-710
    • Sandrini, S.1
  • 8
    • 34250158081 scopus 로고    scopus 로고
    • Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation
    • Patlolla V, Zhong X, Reed GW et al. Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. Am J Transplant 2007; 7: 1832-1842.
    • (2007) Am J Transplant , vol.7 , pp. 1832-1842
    • Patlolla, V.1    Zhong, X.2    Reed, G.W.3
  • 10
    • 5444256681 scopus 로고    scopus 로고
    • Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients
    • DOI 10.1111/j.1432-2277.2004.tb00462.x
    • Vincenti F. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int 2004; 17: 395-401. (Pubitemid 39362567)
    • (2004) Transplant International , vol.17 , Issue.8 , pp. 395-401
    • Vincenti, F.1
  • 12
    • 16244363668 scopus 로고    scopus 로고
    • IL-2-mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP
    • DOI 10.1111/j.1523-1755.2005.00217.x
    • Du C, Guan Q, Yin Z et al. IL-2-mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP. Kidney Int 2005; 67: 1397-1409. (Pubitemid 40463116)
    • (2005) Kidney International , vol.67 , Issue.4 , pp. 1397-1409
    • Du, C.1    Guan, Q.2    Yin, Z.3    Zhong, R.4    Jevnikar, A.M.5
  • 14
    • 38149062103 scopus 로고    scopus 로고
    • Decreased renal ischemia-reperfusion injury by IL-16 inactivation
    • Wang S, Diao H, Guan Q et al. Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int 2008; 73: 318-326.
    • (2008) Kidney Int , vol.73 , pp. 318-326
    • Wang, S.1    Diao, H.2    Guan, Q.3
  • 17
    • 0000989863 scopus 로고
    • Renal tubular epithelial and T cell interactions in autoimmune renal disease
    • Kelley VR, Diaz-Gallo C, Jevnikar AM et al. Renal tubular epithelial and T cell interactions in autoimmune renal disease. Kidney Int Suppl 1993; 39: S108-S115.
    • (1993) Kidney Int Suppl , vol.39
    • Kelley, V.R.1    Diaz-Gallo, C.2    Jevnikar, A.M.3
  • 18
    • 33748510411 scopus 로고    scopus 로고
    • Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury
    • DOI 10.1111/j.1600-6143.2006.01478.x
    • Du C, Wang S, Diao H et al. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemiareperfusion injury. Am J Transplant 2006; 6: 2256-2267. (Pubitemid 44359411)
    • (2006) American Journal of Transplantation , vol.6 , Issue.10 , pp. 2256-2267
    • Du, C.1    Wang, S.2    Diao, H.3    Guan, Q.4    Zhong, R.5    Jevnikar, A.M.6
  • 19
    • 41749096622 scopus 로고    scopus 로고
    • Late kidney allograft loss: What we know about it, and what we can do about it
    • Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008; 3: S56-S67.
    • (2008) Clin J Am Soc Nephrol , vol.3
    • Jevnikar, A.M.1    Mannon, R.B.2
  • 21
    • 0030984291 scopus 로고    scopus 로고
    • Acute rejection of renal allografts: Mechanistic insights and therapeutic options
    • Suthanthiran M. Acute rejection of renal allografts: mechanistic insights and therapeutic options. Kidney Int 1997; 51: 1289-1304. (Pubitemid 27186559)
    • (1997) Kidney International , vol.51 , Issue.4 , pp. 1289-1304
    • Suthanthiran, M.1
  • 24
    • 0031000670 scopus 로고    scopus 로고
    • Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection
    • Suthanthiran M. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Kidney Int Suppl 1997; 58: S15-S21.
    • (1997) Kidney Int Suppl , vol.58
    • Suthanthiran, M.1
  • 25
    • 26944489293 scopus 로고    scopus 로고
    • Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury [1]
    • DOI 10.1111/j.1432-2277.2005.00180.x
    • El-Asir L, Wilson CH, Talbot D. Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury. Transpl Int 2005; 18: 1116. (Pubitemid 41726783)
    • (2005) Transplant International , vol.18 , Issue.9 , pp. 1116
    • El-Asir, L.1    Wilson, C.H.2    Talbot, D.3
  • 26
    • 0028828361 scopus 로고
    • Renal expression of interleukin- 2 receptor mRNA in patients with crescentic glomerulonephritis
    • Jenkins DA, Wojtacha DR, Swan P et al. Renal expression of interleukin- 2 receptor mRNA in patients with crescentic glomerulonephritis. Nephron 1995; 71: 303-308.
    • (1995) Nephron , vol.71 , pp. 303-308
    • Jenkins, D.A.1    Wojtacha, D.R.2    Swan, P.3
  • 28
    • 0031850058 scopus 로고    scopus 로고
    • Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure
    • Schelling JR, Nkemere N, Kopp JB et al. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998; 78: 813-824. (Pubitemid 28347878)
    • (1998) Laboratory Investigation , vol.78 , Issue.7 , pp. 813-824
    • Schelling, J.R.1    Nkemere, N.2    Kopp, J.B.3    Cleveland, R.P.4
  • 29
    • 39049148397 scopus 로고    scopus 로고
    • Cellular FLICE-like inhibitory protein (C-FLIP): A novel target for cancer therapy
    • DOI 10.2174/156800908783497087
    • Safa AR, Day TW,Wu CH. Cellular FLICE-like inhibitory protein (CFLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 2008; 8: 37-46. (Pubitemid 351237908)
    • (2008) Current Cancer Drug Targets , vol.8 , Issue.1 , pp. 37-46
    • Safa, A.R.1    Day, T.W.2    Wu, C.-H.3
  • 30
    • 54249133441 scopus 로고    scopus 로고
    • FLIP and the death effector domain family
    • Yu JW, Shi Y. FLIP and the death effector domain family. Oncogene 2008; 27: 6216-6227.
    • (2008) Oncogene , vol.27 , pp. 6216-6227
    • Yu, J.W.1    Shi, Y.2
  • 32
    • 34247145009 scopus 로고    scopus 로고
    • Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
    • DOI 10.1016/j.canlet.2006.11.013, PII S0304383506006409
    • Zhang L, Zhang X, Barrisford GW et al. Lexatumumab (TRAILreceptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model. Cancer Lett 2007; 251: 146-157. (Pubitemid 46589773)
    • (2007) Cancer Letters , vol.251 , Issue.1 , pp. 146-157
    • Zhang, L.1    Zhang, X.2    Barrisford, G.W.3    Olumi, A.F.4
  • 33
    • 0037444380 scopus 로고    scopus 로고
    • Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel
    • Asakuma J, Sumitomo M, Asano T et al. Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res 2003; 63: 1365-1370. (Pubitemid 36348718)
    • (2003) Cancer Research , vol.63 , Issue.6 , pp. 1365-1370
    • Asakuma, J.1    Sumitomo, M.2    Asano, T.3    Asano, T.4    Hayakawa, M.5
  • 34
    • 33745187572 scopus 로고    scopus 로고
    • Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule- derived cell lines commonly used for in vitro toxicity studies
    • Prozialeck WC, Edwards JR, Lamar PC et al. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule- derived cell lines commonly used for in vitro toxicity studies. Toxicol In Vitro 2006; 20: 942-953
    • (2006) Toxicol in Vitro , vol.20 , pp. 942-953
    • Prozialeck, W.C.1    Edwards, J.R.2    Lamar, P.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.